REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Smaragd Bt. (Csomor) (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Smaragd Patika Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Smaragd Bt. (Csomor) is based in Hungary, with the head office in Csomor. The enterprise operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on December 07, 2001. Smaragd Bt. (Csomor) currently employs 6 (2023) people. There was a net sales revenue increase of 5.45% reported in Smaragd Bt. (Csomor)’s latest financial highlights for 2022. Its’ total assets recorded a negative growth of 5.77%. In 2022, Smaragd Bt. (Csomor)’s net profit margin decreased by 1.71%.

Headquarters
Szabadsag utca 25/A
Csomor; Pest; Postal Code: 2141

Contact Details: Purchase the Smaragd Bt. (Csomor) report to view the information.

Basic Information
Total Employees:
Purchase the Smaragd Bt. (Csomor) report to view the information.
Outstanding Shares:
Purchase the Smaragd Bt. (Csomor) report to view the information.
Registered Capital:
Purchase the Smaragd Bt. (Csomor) report to view the information.
Financial Auditors:
Purchase the Smaragd Bt. (Csomor) report to view the information.
Incorporation Date:
December 07, 2001
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Smaragd Bt. (Csomor) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
5.45%▲
Total operating revenue
5.18%▲
Operating profit (EBIT)
-29.9%▼
EBITDA
-26.88%▼
Net Profit (Loss) for the Period
-29.41%▼
Total assets
-5.77%▼
Total equity
-11.19%▼
Operating Profit Margin (ROS)
-1.89%▼
Net Profit Margin
-1.71%▼
Return on Equity (ROE)
-8.18%▼
Quick Ratio
-0.24%▼
Cash Ratio
-0.22%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo